AbstractAlpha-1-antitrypsin deficiency is a common genetic defect associated with the development of severe and rapidly progressive lung disease. This study was undertaken to determine whether respiratory physicians manage patients with alpha-1-antitrypsin (AAT) deficiency differently from patients with chronic obstructive pulmonary disease (COPD) without alpha-1-antitrypsin deficiency. In addition we obtained physicians' views on who should be tested for AAT deficiency.A questionnaire was administered to 88 respiratory physicians based throughout the U.K. (44 in teaching hospitals). The main outcome measures were pulmonary function tests, radiological assessment, frequency of repeat testing, follow-up and screening protocol for alpha-1-ant...
Chair of Pneumology and Allergology, Department of Internal Medicine, State University of Medicine a...
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that results in debilitating illnesses l...
AbstractMost individuals with AAT deficiency have escaped detection by healthcare systems worldwide....
AbstractAlpha-1-antitrypsin deficiency is a common genetic defect associated with the development of...
Alpha1-antitrypsin (AAT) deficiency, although largely under-diagnosed, is the underlying cause of ap...
AbstractObjectiveTo review the topic of alpha-1 antitrypsin (AAT) deficiency.MethodNarrative literat...
AbstractSettingAbout 1–3% of patients with diagnosed chronic obstructive pulmonary disease (COPD) is...
Alpha-1-antitrypsin deficiency (AATD) is a hereditary disorder that is characterized by a low serum ...
Abstract Objective Alpha-1-antitrypsin deficiency is a relatively prevalent, but under-diagnosed, ge...
Alpha-1 antitrypsin deficiency (AATD) is a hereditary, monogenic disorder with no unique clinical fe...
SummaryBackgroundAlpha1-antitrypsin (AAT) deficiency is an under-diagnosed condition in patients wit...
Alpha-1 antitrypsin (AAT) deficiency is an inherited disorder that causes low levels of, or no AAT i...
Background: Severe alpha-1-antitrypsin deficiency (AATD) is a genetic condition predisposing to chro...
Background and Aims: Chronic obstructive pulmonary disease (COPD) is a kind of pulmonary diseases ch...
α1-antitrypsin deficiency (AATD) remains the only readily identified genetic cause of chronic obstru...
Chair of Pneumology and Allergology, Department of Internal Medicine, State University of Medicine a...
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that results in debilitating illnesses l...
AbstractMost individuals with AAT deficiency have escaped detection by healthcare systems worldwide....
AbstractAlpha-1-antitrypsin deficiency is a common genetic defect associated with the development of...
Alpha1-antitrypsin (AAT) deficiency, although largely under-diagnosed, is the underlying cause of ap...
AbstractObjectiveTo review the topic of alpha-1 antitrypsin (AAT) deficiency.MethodNarrative literat...
AbstractSettingAbout 1–3% of patients with diagnosed chronic obstructive pulmonary disease (COPD) is...
Alpha-1-antitrypsin deficiency (AATD) is a hereditary disorder that is characterized by a low serum ...
Abstract Objective Alpha-1-antitrypsin deficiency is a relatively prevalent, but under-diagnosed, ge...
Alpha-1 antitrypsin deficiency (AATD) is a hereditary, monogenic disorder with no unique clinical fe...
SummaryBackgroundAlpha1-antitrypsin (AAT) deficiency is an under-diagnosed condition in patients wit...
Alpha-1 antitrypsin (AAT) deficiency is an inherited disorder that causes low levels of, or no AAT i...
Background: Severe alpha-1-antitrypsin deficiency (AATD) is a genetic condition predisposing to chro...
Background and Aims: Chronic obstructive pulmonary disease (COPD) is a kind of pulmonary diseases ch...
α1-antitrypsin deficiency (AATD) remains the only readily identified genetic cause of chronic obstru...
Chair of Pneumology and Allergology, Department of Internal Medicine, State University of Medicine a...
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that results in debilitating illnesses l...
AbstractMost individuals with AAT deficiency have escaped detection by healthcare systems worldwide....